Dr. Elena Vasquez
Chief Executive Officer
Two decades scaling biologics CDMOs across three continents. Elena founded Diabryx to give RNA developers a single, accountable end-to-end partner.
Leadership
The people behind the platform
Diabryx is led by scientists and operators who have spent their careers taking complex biologics from concept to clinic to market. They bring deep technical command and an obsessive focus on quality, speed, and partnership.
Dr. Marcus Okonkwo
Chief Scientific Officer
An RNA biochemist who has published widely on capping chemistry and IVT optimization. Marcus leads the science behind every Diabryx platform module.
Priya Tan
Chief Operating Officer
A manufacturing operator who has commissioned and run multiple GMP sites. Priya keeps Diabryx's network running on time, on spec, and on plan.
Dr. Johan Riedel
VP, LNP Formulation
The architect of the FluxMix™ encapsulation platform. Johan's microfluidics expertise turns reproducible formulation into a competitive advantage.
Dr. Amara Chen
VP, Analytical Development
A separations and characterization specialist. Amara builds the modality-specific analytics that give regulators confidence in every batch.
Daniel Moreau
VP, Quality & Regulatory
A quality leader with a track record of clean inspections across multiple jurisdictions. Daniel owns the systems that keep Diabryx audit-ready.
Sofia Krause
VP, Business Development
Sofia partners with biotech and pharma sponsors to scope programs and structure agreements — from a single batch to dedicated commercial supply.
Want to work alongside this team?
We're hiring scientists, engineers, and operators who care as much about RNA medicines as we do.